Noubar Afeyan

Noubar Afeyan is a founding chairman at Cygnal Therapeutics. Noubar has also previously worked with ProFound Therapeutics, Alltrna, Generate Biomedicines, Inc., Tessera Therapeutics, and the Massachusetts Institute of Technology (MIT). In addition, Noubar has also been a part of Omega Therapeutics, Rubius Therapeutics, Moderna Therapeutics, and Flagship Pioneering.

Noubar Afeyan received their PhD in Biochemical Engineering from the Massachusetts Institute of Technology and their BS in Chemical Engineering from McGill University.